Epitomee MedicalEPTMF 30 3-Year RORE % is -19.94 as of Dec. 2025. GuruFocus rates EPTMF with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 782 Medical Devices & Instruments companies, Epitomee Medical ranks better than 73.02% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Epitomee Medical's 3-Year RORE % for the quarter that ended in Dec. 2025 was -19.94%.
The industry rank for Epitomee Medical's 3-Year RORE % or its related term are showing as below:
EPTMF's 3-Year RORE % is ranked better than 73.02% of 782
companies
in the Medical Devices & Instruments industry
Industry Median: -4.31
vs EPTMF: -19.94
Epitomee Medical (OTCPK:EPTMF) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Epitomee Medical 3-Year RORE % Related Terms
Epitomee Medical 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Epitomee Medical's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Epitomee Medical's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epitomee Medical 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Epitomee Medical's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Epitomee Medical (EPTMF) has a 3-Year RORE % of -19.94 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Epitomee Medical and its competitors. According to the industry distribution chart, Epitomee Medical ranks #211 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 27%.
Is Epitomee Medical's 3-Year RORE % too high?
Epitomee Medical's current 3-Year RORE % is -19.94. Based on the distribution chart, Epitomee Medical ranks #211 out of 782 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Epitomee Medical has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epitomee Medical ranks #211 out of 782 companies for 3-Year RORE %. This puts Epitomee Medical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Epitomee Medical and its competitors. Epitomee Medical's current 3-Year RORE % is -19.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current 3-Year RORE % of -19.94. The current 3-Year RORE % is -19.94. Epitomee Medical's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current 3-Year RORE % is -19.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPTMF has been successfully added to your 
